NASDAQ, NURO - Neurometrix Inc
We design, develop and market proprietary medical devices used to help
physicians diagnose and treat diseases of the nervous system such as
neuropathies, which are disorders of the peripheral nerves and parts of the
spine, and neurovascular disorders such as diabetic retinopathy. We are also
developing medical devices designed to be used to provide regional anesthesia
and pain control. To date, our focus has been on products that help physicians
with the diagnosis or detection of neuropathies and neurovascular disorders. We
have two product lines cleared by the United States Food and Drug
Administration, or FDA, that are currently being marketed primarily to
physicians and clinics, including the NC-stat System for the assessment of
neuropathies and the DigiScope for the detection of eye disorders such as
diabetic retinopathy. ...
Read SEC Filing on NASDAQ.com »